Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
Source: [CNBC](https://www.cnbc.com/2026/09/21/lilly-is-ramping-up-future-manufacturing-for-foundayo-obesity-pill.html)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at CNBC ↗